These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. AuNP Coupled Rapid Flow-Through Dot-Blot Immuno-Assay for Enhanced Detection of SARS-CoV-2 Specific Nucleocapsid and Receptor Binding Domain IgG. Sil BK, Jamiruddin MR, Haq MA, Khondoker MU, Jahan N, Khandker SS, Ali T, Oishee MJ, Kaitsuka T, Mie M, Tomizawa K, Kobatake E, Haque M, Adnan N. Int J Nanomedicine; 2021; 16():4739-4753. PubMed ID: 34267520 [Abstract] [Full Text] [Related]
23. Validation of Serological Methods for COVID-19 and Retrospective Screening of Health Employees and Visitors to the São Paulo University Hospital, Brazil. Andreata-Santos R, Machado RRG, Alves RPDS, Sales NS, Soares CP, Rodrigues KB, Silva MO, Favaro MTP, Rodrigues-Jesus MJ, Yamamoto MM, de Andrade JB, Fock RA, Margarido PFR, Carvalho CRG, Boscardin SB, Durigon EL, Ferreira LCS. Front Cell Infect Microbiol; 2022; 12():787411. PubMed ID: 35719329 [Abstract] [Full Text] [Related]
25. Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays. Valdivia A, Torres I, Latorre V, Francés-Gómez C, Albert E, Gozalbo-Rovira R, Alcaraz MJ, Buesa J, Rodríguez-Díaz J, Geller R, Navarro D. Eur J Clin Microbiol Infect Dis; 2021 Mar; 40(3):485-494. PubMed ID: 33404891 [Abstract] [Full Text] [Related]
26. SARS-CoV-2 Antibody Rapid Tests: Valuable Epidemiological Tools in Challenging Settings. Saluzzo F, Mantegani P, Poletti De Chaurand V, Quaresima V, Cugnata F, Di Serio C, Macé A, De Vos M, Sacks JA, Cirillo DM. Microbiol Spectr; 2021 Oct 31; 9(2):e0025021. PubMed ID: 34549999 [Abstract] [Full Text] [Related]
27. Comparative Analysis of Antigen-Specific Anti-SARS-CoV-2 Antibody Isotypes in COVID-19 Patients. Fujigaki H, Inaba M, Osawa M, Moriyama S, Takahashi Y, Suzuki T, Yamase K, Yoshida Y, Yagura Y, Oyamada T, Takemura M, Doi Y, Saito K. J Immunol; 2021 May 15; 206(10):2393-2401. PubMed ID: 33941657 [Abstract] [Full Text] [Related]
30. A systematic and meta-analysis review on the diagnostic accuracy of antibodies in the serological diagnosis of COVID-19. Vengesai A, Midzi H, Kasambala M, Mutandadzi H, Mduluza-Jokonya TL, Rusakaniko S, Mutapi F, Naicker T, Mduluza T. Syst Rev; 2021 May 26; 10(1):155. PubMed ID: 34039423 [Abstract] [Full Text] [Related]
31. Evaluation of serological anti-SARS-CoV-2 chemiluminescent immunoassays correlated to live virus neutralization test, for the detection of anti-RBD antibodies as a relevant alternative in COVID-19 large-scale neutralizing activity monitoring. Cristiano A, Pieri M, Sarubbi S, Pelagalli M, Calugi G, Tomassetti F, Bernardini S, Nuccetelli M. Clin Immunol; 2022 Jan 26; 234():108918. PubMed ID: 34971839 [Abstract] [Full Text] [Related]
38. Evaluation of diagnostic accuracy of 10 serological assays for detection of SARS-CoV-2 antibodies. Gutiérrez-Cobos A, Gómez de Frutos S, Domingo García D, Navarro Lara E, Yarci Carrión A, Fontán García-Rodrigo L, Fraile Torres AM, Cardeñoso Domingo L. Eur J Clin Microbiol Infect Dis; 2021 May 30; 40(5):955-961. PubMed ID: 33236268 [Abstract] [Full Text] [Related]
39. A highly sensitive bead-based flow cytometric competitive binding assay to detect SARS-CoV-2 neutralizing antibody activity. Yao X, Zhang Z, Mei Q, Li S, Xing L, Long Y, Zhang D, Wang J, Wang X, Xie B, Yang B, Gao Y, Wu C, Meng Q. Front Immunol; 2022 May 30; 13():1041860. PubMed ID: 36532082 [Abstract] [Full Text] [Related]